Salamon, Iva
Park, Yongkyu http://orcid.org/0000-0001-6741-6447
Miškić, Terezija
Kopić, Janja
Matteson, Paul
Page, Nicholas F.
Roque, Alfonso
McAuliffe, Geoffrey W.
Favate, John http://orcid.org/0000-0001-6344-4854
Garcia-Forn, Marta
Shah, Premal http://orcid.org/0000-0002-8424-4218
Judaš, Miloš
Millonig, James H.
Kostović, Ivica
De Rubeis, Silvia http://orcid.org/0000-0001-9383-6883
Hart, Ronald P. http://orcid.org/0000-0003-4836-8712
Krsnik, Željka http://orcid.org/0000-0001-5238-6820
Rasin, Mladen-Roko
Article History
Received: 15 November 2022
Accepted: 18 September 2023
First Online: 27 September 2023
Competing interests
: P.S. is a Director at Ananke Therapeutics, a Scientific Advisory Board member of Trestle Biosciences, and consults for Ribo-Therapeutics. Other authors declare no competing interests.